Relative Abundance of <i>EGFR</i> Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

2011243 citationsJournal Article

Authors

The relative EGFR mutation abundance could predict benefit from EGFR-TKI treatment for advanced NSCLC.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 29, Issue 24, pp. 3316-3321

Field-Weighted Citation Impact: 19.44